Sitemap - 2024 - MS-Selfie
Long COVID and its relationship to MS
Q&A 58: TNF-alpha inhibitors and MS
Molecular mimicry: does it explain how EBV causes MS?
Multidisciplinary team meetings or MDTs
Q&A 57: Is my pseudorelapse due to smouldering MS?
Self-agency in MS - is it realistic?
Q&A 56: Natalizumab switching: adverse events on Tyruko
Can we continue to ignore the evidence that T-cells are fundamental to MS?
Q&A 55: Should I have a third course of cladribine?
Smouldering associated or SAW index and MS-CREATE a brain game
Serious infections on anti-CD20 therapies
Q&A 54: switching DMTs due to recurrent infections on ocrelizumab
Gabapentinoids, yet another dirty secret
Q&A 53 - more on tolebrutinib and BTKIs
NHS in crisis: waiting lists, post-code prescribing and more ...
Saving the NHS for people with MS
Q&A 52: timing of your annual flu and COVID-19 vaccines
Q&A 51 - IVF, DMTs and relapses
#1 ECTRIMS 2024 - battle of the BTKi's
Volume 1: Self-management guide for people with multiple sclerosis
Insomnia and multiple sclerosis
Q&A 49 - recurrent UTIs, please help
Q&A 48 - RSV and other vaccines: to vaccinate or not
Smouldering MS: the real MS becomes a tractable problem
Q&A 47: ocrelizumab and pregnancy
Cognitive impairment: is it due to multiple sclerosis or Alzheimer's disease?
Q&A 46 - infections on an anti-CD20
Multiple sclerosis develops long before your first neurological symptoms
Q&A 45 - Not to treat MS and smouldering MS
Primary progressive MS: the forgotten many
Q&A-44 antivirals to treat MS and AHSCT
What to do about MS follow-up consultations that are too short?
Q&A 43: Newly diagnosed PPMS: AHSCT or not?
Smouldering multiple sclerosis: an international consensus
Q&A-42: to do a neurological examination or not
Why is the NHS not delivering?
Q&A 41: To switch from ocrelizumab or not
Are MS treatment algorithms good or bad?
Q&A-40: should I take testosterone replacement therapy?
Q&A 39: can multiple sclerosis cause dementia?
Are ultra-processed foods a problem in multiple sclerosis?
Q&A 38 - to take aciclovir or not
Artificial sweeteners, taste and multiple sclerosis
Q&A 37 - Extended toe and bent knee
Q&A 36: when to do a spinal MRI
Self-management and a rose-tinted-odometer
Q&A 34: ofatumumab and urinary tract infections
Q&A-33 multiple sclerosis and taste
Q&A 32 - Is primary progressive MS different to relapse-onset MS?
Q&A-30 - MS research priorities
Placebo-controlled phase 2 trials
Q&A-29: semaglutide, cannabis and itching
Warning: dangerous counterfeit anti-swallowing devices
Uncertainty associated with MS: are you comfortable with it?
Q&A 28: change in oral cladribine label
Music therapy: under appreciated but not forgotten
Q&A 27: brain reserve, trigonitis and Raynaud's phenomenon
Q&A 26: Anti-CD20 therapy, hypogammaglobulinaemia and infection risk
Q&A 25 - how can MS self-management improve MS outcomes?
How do we make MS services more efficient?
Molluscum contagiosum on fingolimod
Q&A 24 - natalizumab PML, EBV IgM-positive, generic fingolimod
Rectal bleeding: how to approach symptoms that may or may not be related to having MS
Q&A 23 - a clinical trial or not
Will CD19-targeted CAR T-cell therapy cure MS?
Q&A 22 - smouldering MS on ocrelizumab
Will Frexalimab replace the anti-CD20s?
Q&A 21 - diagnosis, relapse and AHSCT
Q&A 20 - remyelination, AHSCT, dental implants, nootropics, ....
Hyper-targeted T-cell therapies
Q&A 19 - Mavenclad, AHSCT & evidence-based medicine
MS-Selfie DMT Infocards version 5.1
Q&A-18: an equivocal new lesion
Is MS a punishment from Allah?
Q&A 17 - beyond no evident inflammatory disease activity or NEIDA